Adicet Bio, Inc.
ACET · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,856 | -$31,217 | -$28,214 | -$28,727 |
| Dep. & Amort. | $868 | -$521 | $1,680 | $1,623 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,529 | $2,908 | $3,180 | $3,773 |
| Change in WC | $1,637 | $58 | -$1,695 | -$206 |
| Other Non-Cash | -$485 | $2,139 | -$348 | -$564 |
| Operating Cash Flow | -$22,307 | -$26,633 | -$25,397 | -$24,101 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$209 | -$47 | -$1,492 | -$176 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$26,955 | $0 | -$34,369 | -$32,944 |
| Inv. Sales/Matur. | $0 | -$33,000 | $33,000 | $11,000 |
| Other Inv. Act. | $44,000 | $66,000 | $0 | $0 |
| Investing Cash Flow | $16,836 | $32,953 | -$2,861 | -$22,120 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$267 | $267 | $0 | $137 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$150 | $0 | -$104 | $14,875 |
| Financing Cash Flow | -$150 | $267 | -$104 | $137 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5,621 | $6,587 | -$28,362 | -$46,084 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37,623 | $31,036 | $59,398 | $105,482 |
| End Cash | $32,002 | $37,623 | $31,036 | $59,398 |
| Free Cash Flow | -$22,516 | -$26,680 | -$26,889 | -$24,277 |